Benzodiazepines (Psy and mixed indications) updated on 02-10-2025

Atrial septal defect

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S15464
R63587
Blotière - Clonazepam (Other indications), 2019 Atrial septal defect 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No BZD Coexposure: No (among antiseizure medications) 1.20 [0.10;4.20] 2/980   3,268/1,875,733 3,270 980
ref
S15593
R64185
Tinker - BZDs, 2019 Atrial septal defect [ASD] secundum or NOS 1st trimester case control unexposed (general population or NOS) Adjustment: Yes BZD Coexposure: Yes (with psychiatric (ATD and/or psychotropics) medications) 1.20 [0.70;1.80] 26/107   2,999/14,451 3,025 107
ref
S15335
R63157
Oberlander - BZDs, 2008 Atrial septal defects (ASD) 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) 1.48 [0.21;10.65] C 1/968   75/107,320 76 968
ref
Total 3 studies 1.21 [0.78;1.89] 6,371 2,055
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Blotière - Clonazepam (Other indications), 2019Blotière - Clonazepam, 2019 1 1.20[0.10; 4.20]3,2709806%ROB confusion: criticalROB selection: moderateROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: moderate Tinker - BZDs, 2019Tinker - BZDs, 2019 1.20[0.70; 1.80]3,02510789%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: unclearROB reporting: moderate Oberlander - BZDs, 2008Oberlander - BZDs, 2008 1.48[0.21; 10.65]769685%ROB confusion: criticalROB selection: moderateROB classification: criticalROB missing: unclearROB mesure: unclearROB reporting: moderate Total (3 studies) I2 = 0% 1.21[0.78; 1.89]6,3712,0550.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Other indications;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.32[0.34; 5.15]3,3461,9480%NABlotière - Clonazepam (Other indications), 2019 Oberlander - BZDs, 2008 2 case control studiescase control studies 1.20[0.75; 1.92]3,025107 -NATinker - BZDs, 2019 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.21[0.78; 1.89]6,3712,0550%NABlotière - Clonazepam (Other indications), 2019 Tinker - BZDs, 2019 Oberlander - BZDs, 2008 3 Tags Adjustment   - No  - No 1.32[0.34; 5.15]3,3461,9480%NABlotière - Clonazepam (Other indications), 2019 Oberlander - BZDs, 2008 2   - Yes  - Yes 1.20[0.75; 1.92]3,025107 -NATinker - BZDs, 2019 1 BZD Coexposure   - No (among antiseizure medications)  - No (among antiseizure medications) 1.20[0.19; 7.78]3,270980 -NABlotière - Clonazepam (Other indications), 2019 1   - No (among psychiatric (ATD and/or p ...  - No (among psychiatric (ATD and/or psychotropics) medications) 1.48[0.21; 10.65]76968 -NAOberlander - BZDs, 2008 1   - Yes (with psychiatric (ATD and/or p ...  - Yes (with psychiatric (ATD and/or psychotropics) medications) 1.20[0.75; 1.92]3,025107 -NATinker - BZDs, 2019 1 All studiesAll studies 1.21[0.78; 1.89]6,3712,0550%NABlotière - Clonazepam (Other indications), 2019 Tinker - BZDs, 2019 Oberlander - BZDs, 2008 30.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.21[0.78; 1.89]6,3712,0550%NABlotière - Clonazepam (Other indications), 2019 Tinker - BZDs, 2019 Oberlander - BZDs, 2008 30.510.01.0